[Anticoagulant treatment following thrombolytic therapy].
D005017:Ethyl Biscoumacetate / Q000627:therapeutic use*; D006470:Hemorrhage / Q000209:etiology; D006493:Heparin / Q000009:adverse effects*; D006801:Humans; D013300:Streptokinase / Q000627:therapeutic use*; D013923:Thromboembolism / Q000188:drug therapy*; D013925:Thromboplastin
D005017:Ethyl Biscoumacetate; D006493:Heparin; D013925:Thromboplastin; D013300:Streptokinase
Antikoagulantienbehandlung nach thrombolytischer Therapie.